In vivo cytokine responses to interleukin-2 immunotherapy after autologous stem cell transplantation in children with solid tumors (Q74082607)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918410 AND SRC:MED&resulttype=core&format=json

8 November 2019

title

In vivo cytokine responses to interleukin-2 immunotherapy after autologous stem cell transplantation in children with solid tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918410 AND SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

stem cell transplantation

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918410 AND SRC:MED&resulttype=core&format=json

8 November 2019

author name string

Laws HJ

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918410 AND SRC:MED&resulttype=core&format=json

8 November 2019

Wundes A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918410 AND SRC:MED&resulttype=core&format=json

8 November 2019

Verheyen J

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918410 AND SRC:MED&resulttype=core&format=json

8 November 2019

Hannen M

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918410 AND SRC:MED&resulttype=core&format=json

8 November 2019

Kim YM

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918410 AND SRC:MED&resulttype=core&format=json

8 November 2019

Banning U

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918410 AND SRC:MED&resulttype=core&format=json

8 November 2019

Nürnberger W

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918410 AND SRC:MED&resulttype=core&format=json

8 November 2019

Körholz D

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918410 AND SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918410 AND SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918410 AND SRC:MED&resulttype=core&format=json

8 November 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918410 AND SRC:MED&resulttype=core&format=json

8 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918410 AND SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

91-96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918410 AND SRC:MED&resulttype=core&format=json

Interleukin-2: use in solid tumors

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702431

7 January 2021

Clinical and immunomodulatory effects of repetitive 2-day cycles of high-dose continuous infusion IL-2

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702431

7 January 2021

Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapy

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702431

7 January 2021

Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantation

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702431

7 January 2021

Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702431

7 January 2021

Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702431

7 January 2021

Differential role for IL-2 and IL-15 in the inhibition of apoptosis in short-term activated human lymphocytes

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702431

7 January 2021

Temporal sequence and cellular origin of interleukin-2 stimulated cytokine gene expression

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702431

7 January 2021

Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702431

7 January 2021

High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702431

7 January 2021

In vivo stimulation of IL-12 secretion by subcutaneous low-dose IL-2 in metastatic cancer patients

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702431

7 January 2021

IL-2 infusion abrogates humoral immune responses in humans

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702431

7 January 2021

Interleukin-2 augmentation of interleukin-1 and prostaglandin E2 production

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702431

7 January 2021

Regulation of interleukin-2 induced interleukin-5 and interleukin-13 production in human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702431

7 January 2021